73 views
Lennox-Gastaut syndrome is one of the most complex forms of epilepsy, characterized by drug-resistant seizures and a significant impact on the quality of life of patients, especially children. This rare neurological condition, which often manifests in preschool age, involves severe cognitive, behavioral and motor difficulties, making a targeted and innovative therapeutic approach crucial. Recently, fenfluramine has opened new perspectives in the treatment of this syndrome. Approved by AIFA for its reimbursement, it stands out for its ability to reduce the most disabling epileptic seizures and improve cognitive and relational functions, offering hope to those living with this complex pathology. Thanks to its multiple mechanisms of action, fenfluramine fits effectively into the therapeutic arsenal, ensuring benefits not only on seizure control, but also on behavioral aspects and overall quality of life of patients. However, the transition to adulthood remains a significant challenge: the lack of a structured network that facilitates the transition from child neuropsychiatrists to adult neurologists risks compromising holistic care. Collaboration between specialists and families is therefore essential to ensure continuous and personalized support. This innovative therapeutic approach, together with a better understanding of the needs of patients and their caregivers, could represent a turning point in the management of Lennox-Gastaut syndrome. To find out more about these innovations and stay updated on other important health topics, subscribe to our channel and activate notifications. Don't miss the opportunity to always be informed about the latest discoveries that can make a difference! ????️ Interviews with: - Bernardo Dalla Bernardina - Full Professor of Child Neuropsychiatry University of Verona, Research Center for Pediatric Epilepsies, AOUI Ospedale Donna e Bambino di Verona; - Antonietta Coppola - Epilepsy Center, Department of Neurosciences, Reproductive and Odontostomatological Sciences - Federico II University Hospital in Naples. #DrugResistantEpilepsy #Fenfluramine #LennoxGastautSyndrome #InnovativeTherapies #NeurologicalHealth ********************* ???? Follow us! WebTV: https://PianetaSalute.TV Magazine: https://www.PianetaSalute.online Instagram: / pianetasalute2.0 Twitter: / pianetasalute Facebook: / pianetasalute Linkedin: / pianeta-salute-tv WhatsApp: https://whatsapp.com/channel/0029VaDP... Telegram: https://t.me/pianetasalute Digital terrestrial: National channel 221 Pianeta Salute TV (00:00) - News on the treatment of Lennox-Gastaut syndrome (00:39) - Characteristics of Lennox-Gastaut syndrome (01:25) - Difficulties and diagnosis of LG (02:15) - Role of fenfluramine in treatment (03:40) - Problems in the transition from pediatric age to adulthood (05:49) - The importance of the doctor-family relationship (07:31) - Management of the adult patient with LG and fenfluramine (09:09) - Cognitive and Behavioral Benefits of Fenfluramine